Concord Biotech shares up over 27% in debut rally

New Delhi: Shares of Concord Biotech ended with a premium of over 27 per cent against the issue price of Rs741 in its debut trade on Friday. The stock began the trade at Rs900.05, registering a jump of 21.46 per cent against the issue price on the BSE. During the day, it zoomed 33.20 per cent to Rs987.05. Shares of the company ended at Rs941.85, up 27.10 per cent. At the NSE, it listed at Rs900.05 and further rallied 33.29 per cent to Rs987.70. The stock ended at Rs943.50, a gain of 27.32 per cent. The company commanded a market valuation of Rs9,853.28 crore. In traded volume terms, 15.45 lakh shares of the firm were traded on the BSE and over 2.42 crore shares on the NSE during the day.